EMRYX
Price
$17.12
Change
-$0.06 (-0.35%)
Updated
Nov 19 closing price
Net Assets
325.26M
VEIEX
Price
$34.03
Change
-$0.05 (-0.15%)
Updated
Nov 19 closing price
Net Assets
141.19B
Interact to see
Advertisement

EMRYX vs VEIEX

Header iconEMRYX vs VEIEX Comparison
Open Charts EMRYX vs VEIEXBanner chart's image
VanEck Emerging Markets Y
Price$17.12
Change-$0.06 (-0.35%)
VolumeN/A
Net Assets325.26M
Vanguard Emerging Mkts Stock Idx I
Price$34.03
Change-$0.05 (-0.15%)
VolumeN/A
Net Assets141.19B
EMRYX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
EMRYX vs. VEIEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMRYX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 141B vs. EMRYX (325M). VEIEX pays higher dividends than EMRYX: VEIEX (2.61) vs EMRYX (1.17). EMRYX was incepted earlier than VEIEX: EMRYX (16 years) vs VEIEX (32 years). EMRYX (1.23) is less costly to investors than VEIEX (0.29). EMRYX is a more actively managed with annual turnover of: 19.00 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than EMRYX: VEIEX (0) vs EMRYX (1000). EMRYX annual gain was more profitable for investors over the last year : 21.75 vs. VEIEX (20.18). VEIEX return over 5 years is better than : 23.38 vs. EMRYX (-9.21).
EMRYXVEIEXEMRYX / VEIEX
Total Expense Ratio1.120.29386%
Annual Report Gross Expense Ratio1.230.29424%
Fund Existence16 years32 years-
Gain YTD26.90922.205121%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets325M141B0%
Annual Yield % from dividends1.172.6145%
Returns for 1 year21.7520.18108%
Returns for 3 years43.1147.2391%
Returns for 5 years-9.2123.38-39%
Returns for 10 years42.4778.6154%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE0.58N/A
+0.02%
Cue Biopharma
RNGR13.51N/A
N/A
Ranger Energy Services
MTSR70.50N/A
N/A
Metsera Inc
CHPGU10.26N/A
N/A
Championsgate Acquisition Corp
TRVI11.05-0.26
-2.30%
Trevi Therapeutics